Literature DB >> 22687640

Obesity comorbidity in unipolar major depressive disorder: refining the core phenotype.

Robert D Levitan1, Caroline Davis, Allan S Kaplan, Tamara Arenovich, D I W Phillips, Arun V Ravindran.   

Abstract

OBJECTIVE: While a significant body of research has demonstrated high comorbidity rates between depression and obesity, the vast majority of this work has considered depression as a unitary diagnosis. Given that increased appetite and weight gain are highly characteristic of the "atypical" subtype of depression, while classic depression is characterized by decreased appetite and weight loss, it would be important to examine whether increased obesity risk is consistent across the major vegetative subtypes of depression or is limited to the atypical subtype.
METHOD: Using data from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), we identified 5,092 US adults with past or current major depression based on DSM-IV-TR criteria and 1,500 gender-matched controls. Each depressed subject was designated as having classic, atypical, or undifferentiated depression based on core vegetative symptoms. Logistic regression models examined rates of current obesity (defined as a current body mass index [kg/m2] > 30) across the 3 depressive subgroups and nondepressed controls, adjusting for demographic differences. To limit the possible effect of current depressive symptoms on observed obesity rates, secondary analyses were completed in individuals with past depression only.
RESULTS: Subjects with atypical depression had markedly elevated obesity rates compared to population controls and to other depressed subjects, with corresponding pairwise odds ratios consistently greater than 2.0 (P < .001). In contrast, obesity rates were not significantly different in subjects with classic depression and nondepressed controls. These results were manifest in individuals with either current or past depression and were independent of gender and age.
CONCLUSIONS: While many individuals with classic depression will present with obesity due to the high prevalence of both disorders, only atypical depression is associated with an elevated risk of obesity relative to the population at large. Refining the target phenotype(s) for future work on depression and obesity might improve our understanding, prevention, and treatment of this complex clinical problem. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22687640     DOI: 10.4088/JCP.11m07394

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  29 in total

Review 1.  Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Authors:  Lucile Capuron; Julie Lasselin; Nathalie Castanon
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

Review 2.  Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders.

Authors:  Rita Barandas; Dominic Landgraf; Michael J McCarthy; David K Welsh
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

3.  Psychosocial Predictors of Change in Depressive Symptoms Following Gastric Banding Surgery.

Authors:  Kymberlie Preiss; David Clarke; Paul O'Brien; Xochitl de la Piedad Garcia; Annemarie Hindle; Leah Brennan
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

4.  Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice.

Authors:  Wenqi Gao; Wei Wang; Jing Zhang; Pengyi Deng; Jun Hu; Jian Yang; Zhifang Deng
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

5.  Depressive Disorder Subtypes as Predictors of Incident Obesity in US Adults: Moderation by Race/Ethnicity.

Authors:  Brittanny M Polanka; Elizabeth A Vrany; Jay Patel; Jesse C Stewart
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

Review 6.  The brain-adipocyte-gut network: Linking obesity and depression subtypes.

Authors:  Carla M Patist; Nicolas J C Stapelberg; Eugene F Du Toit; John P Headrick
Journal:  Cogn Affect Behav Neurosci       Date:  2018-12       Impact factor: 3.282

7.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

8.  Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression.

Authors:  Sara A Khedr; Ahmed A Elmelgy; Omnyah A El-Kharashi; Hadwa A Abd-Alkhalek; Manal L Louka; Hoda A Sallam; Sawsan Aboul-Fotouh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-29       Impact factor: 3.000

Review 9.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

10.  Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Authors:  Larry Culpepper
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.